FDA updates labeling for XTANDI FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for ASTELLAS. Active ingredient: ENZALUTAMIDE. Decision date: 12/11/2025 Full text
There are no comments here yet...